Related content

Clinical significance of SF3B1 mutations in Korean patients with myelodysplastic syndromes and myelodysplasia/myeloproliferative neoplasms with ring sideroblasts

By Seo Ja   Lee Ki-O   Kim Sun-Hee   Kim Kihyun   Jung Chul   Jang Jun   Kim Hee-Jin  

Annals of Hematology, Vol. 93, Iss. 4, 2014-04 ,pp. : 603-608

Springer Publishing Company

Access to resources Recommend Favorite

The implication of identifying JAK2 V617F in myeloproliferative neoplasms and myelodysplastic syndromes with bone marrow fibrosis

By Olsen Randall  

Journal of Hematopathology, Vol. 1, Iss. 2, 2008-09 ,pp. : 111-117

Springer Publishing Company

Access to resources Recommend Favorite

Effects of prednisone and splenectomy in patients with idiopathic thrombocytopenic purpura: only splenectomy induces a complete remission

By Louwes H.   Vellenga E.   Houwerzijl E.   de Wolf J.  

Annals of Hematology, Vol. 80, Iss. 12, 2001-12 ,pp. : 728-732

Springer Publishing Company

Access to resources Recommend Favorite

Review of therapeutic options and the management of patients with myelodysplastic syndromes

By Özcan Mehmet A   Ilhan Osman   Ozcebe Osman I   Nalcaci Meliha   Gülbas Zafer  

Expert Review of Hematology, Vol. 6, Iss. 2, 2013-04 ,pp. : 165-189

Informa Healthcare

Access to resources Recommend Favorite

Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions

By Douet-Guilbert Nathalie  

Annals of Hematology, Vol. 87, Iss. 7, 2008-07 ,pp. : 537-544

Springer Publishing Company

Access to resources Recommend Favorite